Soc. Generale Knock-Out DVA/ DE000SN31395 /
9/6/2024 9:43:50 PM | Chg.+0.150 | Bid9:58:56 PM | Ask9:58:56 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
7.650EUR | +2.00% | 7.650 Bid Size: 2,000 |
7.690 Ask Size: 2,000 |
DaVita Inc | 66.2575 USD | 12/31/2078 | Call |
GlobeNewswire
6/24
BayMark Health Services Announces Leadership Transition: David White Steps Down as CEO; Marshal Salo...
Newsfile Corp
6/18
Healing Realty Trust Closes First Tranche of Series A to Expand Clinic-Focused Portfolio for a New G...
GlobeNewswire
4/26
Benevity’s 2024 Corporate Goodness Awards Celebrate Groundbreakers in Social Impact
GlobeNewswire
11/17/2023
Outstanding 12-month first-in-human data from Xeltis’ aXess hemodialysis vascular conduit trial pres...
GlobeNewswire
8/15/2023
Elevar Therapeutics Names Dr. Chris Galloway Vice President of Clinical Development
GlobeNewswire
3/21/2022
Chinook Therapeutics Announces Appointment of Dr. Mahesh Krishnan to its Board of Directors
GlobeNewswire
3/7/2022
The Oncology Institute Announces Promotions for Dr. Daniel Virnich and Dr. Matt Miller
GlobeNewswire
2/10/2022
Miromatrix to Ring Nasdaq Closing Bell on National Donor Day, February 14, 2022
GlobeNewswire
10/7/2021
Miromatrix Announces the First Successful Transplant of a Bioengineered Whole Organ in a Large Anima...
GlobeNewswire
10/1/2021
AAON Increases Board Size and Appoints Bruce Ware and David Stewart as Independent Directors